Ontario Supports World-Class Science

The Government of Ontario is supporting world-class biomedical research by matching renowned University of Toronto cell biologist Dr. Anthony Pawson’s $500,000 Kyoto Prize.

TORONTO--(BUSINESS WIRE)--The Government of Ontario is supporting world-class biomedical research by matching renowned University of Toronto cell biologist Dr. Anthony Pawson’s $500,000 Kyoto Prize.

Dr. Pawson conducts research at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto. His discoveries have been instrumental in the fight against diseases including diabetes and cancer. His work has also led to the development of a new generation of drugs that stop the growth of diseases like cancer. He is one of the first Canadians to receive the Kyoto Prize.

Supporting world-class research is part of the Ontario government’s Innovation Agenda and five-point plan for growing Ontario’s economy.

“Ontario is proud to recognize Dr. Pawson for his groundbreaking work. I am pleased to once again demonstrate our government’s commitment to science by investing in Ontario’s greatest asset &ndash our people. It is their imagination, talent, skills and hard work today that will strengthen our economy, improve our lives and create good jobs for the future,” said Minister of Research and Innovation John Wilkinson.

“The fact that the Ontario government is matching the Kyoto Prize is very exciting &ndash it establishes a very real bond between Ontario and Kyoto, two globally recognized centres of scientific excellence. This enlightened support is essential to maintain the outstanding quality of biomedical research in Ontario, and to promote the careers of outstanding young scientists who will be the research leaders of the future,” said Dr. Pawson.

“We are delighted that the government continues to lead Ontario forward with its research and innovation agenda. The University of Toronto community takes particular pride in Professor Pawson’s path-breaking scientific research &ndash research that has already led to life-saving advances in the field of cancer therapeutics,” said University of Toronto President David Naylor.

QUICK FACTS


TechConnect Wire™ press releases...

Annual Meeting

TechConnect World 2015